International Stem Cell (ISCO) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
International Stem Cell (ISCO) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 39.85 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 17.55 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 39.27 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -33.00 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 17.37 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 31.95 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 22.25 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 107.60 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 48.48 Mn |
| 10 | International Stem Cell | 3.36 Mn | 2.27 Mn | 1.46 Mn | 1.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Dec 31, 2025 | 946,000.00 |
| Sep 30, 2025 | 789,000.00 |
| Jun 30, 2025 | 905,000.00 |
| Mar 31, 2025 | 892,000.00 |
| Dec 31, 2024 | 907,000.00 |
| Sep 30, 2024 | 816,000.00 |
| Jun 30, 2024 | 884,000.00 |
| Mar 31, 2024 | 909,000.00 |
| Dec 31, 2023 | 964,000.00 |
| Sep 30, 2023 | 832,000.00 |
| Jun 30, 2023 | 918,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 845,000.00 |
| Sep 30, 2022 | 808,000.00 |
| Jun 30, 2022 | 872,000.00 |
| Mar 31, 2022 | 832,000.00 |
| Dec 31, 2021 | 894,000.00 |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.01 Mn |